Search

… Authorization of Moderna COVID-19 Vaccine with English-only Vial and Carton Labels Starting … On December 23, 2020, Moderna COVID-19 Vaccine (COVID-19 mRNA Vaccine) (DIN 02510014) was authorized in accordance …

… SPIKEVAX Bivalent (Original / Omicron BA.4/5) (elasomeran/davesomeran) COVID-19 Vaccine with English-only Vial and Carton Labels … 3, 2022 . In order to provide rapid access to the vaccine, Moderna will distribute product vials and cartons labelled in …

… Distribution of SPIKEVAX Bivalent (elasomeran/imelasomeran) COVID-19 Vaccine with English-only Vial and Carton Labels … . In order to provide rapid access to SPIKEVAX Bivalent , Moderna will distribute product vials and cartons labelled in …

… Distribution of a New Presentation of SPIKEVAX (elasomeran) COVID-19 Vaccine (0.10 mg/mL in 2.5 mL multidose vial) with … of SPIKEVAX (0.1 0 mg/mL, 2.5 mL multidose vial), Moderna will distribute vaccine product with English-only …

… Importation of AstraZeneca COVID-19 Vaccine with English-only Vial and Carton Labels … during the initial distribution of the AstraZeneca COVID-19 Vaccine (US-labelled vaccine supplies) Audience …

… Authorization of Pfizer-BioNTech COVID-19 Vaccine with English-only Carton and Vial Labels Starting … 9, 2020, Pfizer-BioNTech COVID-19 Vaccine (COVID-19 mRNA Vaccine) (DIN 02509210) was authorized in accordance …

… Authorization of AstraZeneca COVID-19 Vaccine with English-only Vial and Carton Labels Starting … during the initial distribution of the AstraZeneca COVID-19 Vaccine. Audiences Healthcare professionals …

… and distributor) is initially distributing COVISHIELD (COVID-19 Vaccine) doses directly to vaccination locations where … (manufactured by Serum Institute of India) and AstraZeneca COVID-19 VACCINE (manufactured by AstraZeneca) are ChAdOx1-S …

… with English-only Labels for Use in Relation to the COVID-19 Pandemic Starting date: December 18, 2020 Posting date: … Sale and Advertising of Drugs for Use in Relation to COVID-19 . Bamlanivimab is indicated for the treatment of …

… seek medical help immediately. To help limit the spread of COVID-19, wash your hands often with soap and water for at least 20 … (DIN) but have been accepted for use in Canada during the COVID-19 pandemic. Report any health product  adverse events …

… AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Capillary Leak Syndrome … have been reported following vaccination with AstraZeneca COVID-19 Vaccine. A history of CLS was noted in some of the …

… AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Thrombosis with … very rarely following vaccination with the AstraZeneca COVID-19 Vaccine. Health Canada has assessed the available data on …

… Authorization of Janssen COVID-19 Vaccine with English-only Vial and Carton Labels Starting … information during the initial distribution of the Janssen COVID-19 Vaccine. Audience Healthcare professionals including …

… Pfizer-BioNTech COVID-19 Vaccine: Updated Dosage and Administration and Post-Market … the PM for Pfizer-BioNTech COVID-19 Vaccine (COVID-19 mRNA Vaccine) to reflect this new information. Health Canada …

… of Sotrovimab for Injection for Use in Relation to the COVID-19 Pandemic Starting date: September 22, 2021 Posting date: … Sale and Advertising of Drugs for Use in Relation to COVID-19 . Sotrovimab is indicated for the treatment of mild …